The National Academies Press

Currently Skimming:

Roundtable on Genomics and Precision Health: 2020 Annual Report
Pages 1-8

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 1... ... Current areas of emphasis are described in greater detail below and include innovations in the discovery and development of precision therapeutics and technologies, clinical implementation of genomic medicine, inequities in the research database, workforce, and access to genetic services, and fostering a dialogue across stakeholders within genomics and precision health. To achieve its objectives, the Roundtable conducts structured discussions, meetings, public workshops, enters into information-gathering activities, develops authored viewpoints and perspectives, organizes and supports collaboratives, and publishes workshop proceedings. Read the entire page →
From page 2... ... The Innovation group explores competing barriers and facilitators of innovation for genomics based diagnostics, risk assessment tools, and therapies, and leverages INNOVATION opportunities to learn from and promote innovative approaches that can accelerate commercialization and integration to drive impact of genomics on precision health. Currently, the group is focusing on lessons learned from case studies of successful innovation that could help in the development of an innovation "playbook." The Shaping the Dialogue working group accelerates the dissemination of actionable DIALOGUE knowledge to shape practice and increase public awareness. Read the entire page →
From page 3... ... Released: March 19, 2020 Meetings March 25, 2020 July 1, 2020 The Roundtable debriefed following the workshop on digital The Roundtable met virtually with the Standing Committee on health technologies in drug development and explored the Emerging Infectious Diseases and 21st Century Health Threats decision-making process for identifying and integrating digital to explore innovative approaches for studying host (human) health technologies in health systems with invited leaders genetic and genomic factors associated with susceptibility from those health systems. Read the entire page →
From page 4... ... Jennifer Goldsack, M.Chem., M.A., M.B.A. Air Force Medical Support Agency Digital Medicine Society (DiMe) Read the entire page →
From page 5... ... American Society of Human Genetics Myriad Women's Health Association for Molecular Pathology National Cancer Institute Biogen National Human Genome Research Institute Blue Cross and Blue Shield Association National Institute of Mental Health College of American Pathologists National Institute of Nursing Research Color Genomics National Institute on Aging Department of Veterans Affairs National Institutes of Health All of Us Research Program Eisai Inc. National Institutes of Health Office of Disease Prevention Geisinger National Society of Genetic Counselors Genosity Pfizer Inc. Read the entire page →
From page 6... ... Roundtable Timeline 2007 2012 November 20: Meeting 27 July 11−12: Meeting 1 March 21: New Paradigms in Drug Discovery: How 2016 Genomic Data Are Being Used to Revolutionize December 4: Diffusion and Use of Genomic the Drug Discovery and Development Process March 22: Deriving Drug Discovery Value from Innovations in Health and Medicine Workshop Workshop Large-Scale Genetic Bioresources Workshop December 5: Meeting 2 March 23: Meeting 28 March 22: Meeting 16 2008 May 24: Evidence for Clinical Utility of Molecular July 19-20: Meeting 29 Diagnostics in Oncology Workshop November 9: Meeting 30 April 1−2: Meeting 3 July 17−18: Assessing the Economics of Genomic July 28: Innovations in Service Delivery in the Age Medicine Workshop 2017 of Genomics Workshop July 18: Meeting 17 March 8: Enabling Precision Medicine: The Role of July 29: Meeting 4 October 4−5: Sharing Clinical Research Data Genetics in Clinical Drug Development Workshop October 6−7: Meeting 5 Workshop March 9: Meeting 31 2009 December 3: Improving the Efficiency and July 17-18: Meeting 32 Effectiveness of Genomic Science Translation November 1: Implementing and Evaluating February 12: Systems for Research and Evaluation Workshop Genomic Screening Programs in Health Care for Translating Genome-Based Discoveries for December 4: Meeting 18 Systems Workshop Health Workshop 2013 November 2: Meeting 33 February 13: Meeting 6 June 9−11: Meeting 7 February 27: Refining Processes for the Co- 2018 August 31-September 1: Direct-to-Consumer Development of Genome-Based Therapeutics and March 20: Meeting 34 Genetic Testing Workshop Companion Diagnostic Tests Workshop June 27: Understanding Disparities in Access to November 16−17: Meeting 8 February 28: Meeting 19 Genomic Medicine Workshop June 5: Conflict of Interest and Medical Innovation: 2010 June 28: Meeting 35 Ensuring Integrity While Facilitating Innovation in Medical Research Workshop October 5: Virtual Meeting on Return of Research March 22: The Value of Genetic and Genomic Results Technologies Workshop June 24: Genomics-Enabled Drug Repositioning and Drug Repurposing Workshop March 23: Meeting 9 2019 June 25: Meeting 20 May 24: Challenges and Opportunities in Using January 23-24: Meeting with Keystone Symposia Newborn Screening Samples for Translational December 4−5: Meeting 21 and American College of Cardiology Research Workshop; Meeting 10 2014 March 27-28: Meeting 36 July 22: Establishing Precompetitive Collaborations to Stimulate Genomics- Driven Drug Development June 25-26: Meeting 37 February 3: Assessing Genomic Sequencing Workshop Information for Health Care Decision Making October 29-30: Meeting 38 July 23: Meeting 11 Workshop 2020 November 17: Generating Evidence for Genomic February 4: Meeting 22 Diagnostic Test Development Workshop August 18: Improving Genetics Education in March 24: The Role of Digital Health Technologies in Graduate and Continuing Health Professional Drug Development Workshop November 18: Meeting 12 Education Workshop March 25: Meeting 39 2011 August 19: Meeting 23 June 22-23: Meeting 40: Strategic Planning February 22−23: Meeting 13 December 8: Genomics-Enabled Learning Health Care Systems: Gathering and Using Genomic July 1: Meeting 41: Host Genomics Research and Data July 19: Integrating Large-Scale Genomic Information to Improve Patient Care and Research Collection Efforts Related to COVID-19 Information into Clinical Practice Workshop Workshop July 20: Meeting 14 November 10 & 12: Meeting 42: Implementation of December 9: Meeting 24 Strategic Plan November 15: Facilitating Development and Utilization of Genome-Based Diagnostic 2015 2021 Technologies Workshop March 10−11: Meeting 25 January 28: Meeting 43 November 16: Meeting 15 July 14−15: Meeting 26 March 15-16: Meeting 44 November 19: Applying an Implementation July 14-15: Meeting 45 Science Approach to Genomic Medicine Workshop October 5-6: Meeting 46 2020 Annual Report \| 6 Read the entire page →
From page 7... ... Board on Health Sciences Policy Staff NAM Greenwall Fellow in Bioethics Andrew Pope, Ph.D., Senior Board Director Rachel Fabi, Ph.D., Upstate Medical University Bridget Borel, Program Coordinator ABOUT THE NATIONAL ACADEMIES The National Academy of Sciences, National Academy of Engineering, and National Academy of Medicine work together as the National Academies of Sciences, Engineering, and Medicine ("the Academies") to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. Read the entire page →
From page 8... ... The nation turns to the National Academies of Sciences, Engineering, and Medicine for independent, objective advice on issues that affect people's lives worldwide. www.nationalacademies.org To learn more about the Roundtable, visit nationalacademies.org/our-work/Roundtable-on genomics-and-precision-health Read the entire page →

From page 1...

... Current areas of emphasis are described in greater detail below and include innovations in the discovery and development of precision therapeutics and technologies, clinical implementation of genomic medicine, inequities in the research database, workforce, and access to genetic services, and fostering a dialogue across stakeholders within genomics and precision health. To achieve its objectives, the Roundtable conducts structured discussions, meetings, public workshops, enters into information-gathering activities, develops authored viewpoints and perspectives, organizes and supports collaboratives, and publishes workshop proceedings.

Read the entire page →

From page 2...

... The Innovation group explores competing barriers and facilitators of innovation for genomics based diagnostics, risk assessment tools, and therapies, and leverages INNOVATION opportunities to learn from and promote innovative approaches that can accelerate commercialization and integration to drive impact of genomics on precision health. Currently, the group is focusing on lessons learned from case studies of successful innovation that could help in the development of an innovation "playbook." The Shaping the Dialogue working group accelerates the dissemination of actionable DIALOGUE knowledge to shape practice and increase public awareness.

Read the entire page →

From page 3...

... Released: March 19, 2020 Meetings March 25, 2020 July 1, 2020 The Roundtable debriefed following the workshop on digital The Roundtable met virtually with the Standing Committee on health technologies in drug development and explored the Emerging Infectious Diseases and 21st Century Health Threats decision-making process for identifying and integrating digital to explore innovative approaches for studying host (human) health technologies in health systems with invited leaders genetic and genomic factors associated with susceptibility from those health systems.

Read the entire page →

From page 4...

... Jennifer Goldsack, M.Chem., M.A., M.B.A. Air Force Medical Support Agency Digital Medicine Society (DiMe)

Read the entire page →

From page 5...

... American Society of Human Genetics Myriad Women's Health Association for Molecular Pathology National Cancer Institute Biogen National Human Genome Research Institute Blue Cross and Blue Shield Association National Institute of Mental Health College of American Pathologists National Institute of Nursing Research Color Genomics National Institute on Aging Department of Veterans Affairs National Institutes of Health All of Us Research Program Eisai Inc. National Institutes of Health Office of Disease Prevention Geisinger National Society of Genetic Counselors Genosity Pfizer Inc.

Read the entire page →

From page 6...

... Roundtable Timeline 2007 2012 November 20: Meeting 27 July 11−12: Meeting 1 March 21: New Paradigms in Drug Discovery: How 2016 Genomic Data Are Being Used to Revolutionize December 4: Diffusion and Use of Genomic the Drug Discovery and Development Process March 22: Deriving Drug Discovery Value from Innovations in Health and Medicine Workshop Workshop Large-Scale Genetic Bioresources Workshop December 5: Meeting 2 March 23: Meeting 28 March 22: Meeting 16 2008 May 24: Evidence for Clinical Utility of Molecular July 19-20: Meeting 29 Diagnostics in Oncology Workshop November 9: Meeting 30 April 1−2: Meeting 3 July 17−18: Assessing the Economics of Genomic July 28: Innovations in Service Delivery in the Age Medicine Workshop 2017 of Genomics Workshop July 18: Meeting 17 March 8: Enabling Precision Medicine: The Role of July 29: Meeting 4 October 4−5: Sharing Clinical Research Data Genetics in Clinical Drug Development Workshop October 6−7: Meeting 5 Workshop March 9: Meeting 31 2009 December 3: Improving the Efficiency and July 17-18: Meeting 32 Effectiveness of Genomic Science Translation November 1: Implementing and Evaluating February 12: Systems for Research and Evaluation Workshop Genomic Screening Programs in Health Care for Translating Genome-Based Discoveries for December 4: Meeting 18 Systems Workshop Health Workshop 2013 November 2: Meeting 33 February 13: Meeting 6 June 9−11: Meeting 7 February 27: Refining Processes for the Co- 2018 August 31-September 1: Direct-to-Consumer Development of Genome-Based Therapeutics and March 20: Meeting 34 Genetic Testing Workshop Companion Diagnostic Tests Workshop June 27: Understanding Disparities in Access to November 16−17: Meeting 8 February 28: Meeting 19 Genomic Medicine Workshop June 5: Conflict of Interest and Medical Innovation: 2010 June 28: Meeting 35 Ensuring Integrity While Facilitating Innovation in Medical Research Workshop October 5: Virtual Meeting on Return of Research March 22: The Value of Genetic and Genomic Results Technologies Workshop June 24: Genomics-Enabled Drug Repositioning and Drug Repurposing Workshop March 23: Meeting 9 2019 June 25: Meeting 20 May 24: Challenges and Opportunities in Using January 23-24: Meeting with Keystone Symposia Newborn Screening Samples for Translational December 4−5: Meeting 21 and American College of Cardiology Research Workshop; Meeting 10 2014 March 27-28: Meeting 36 July 22: Establishing Precompetitive Collaborations to Stimulate Genomics- Driven Drug Development June 25-26: Meeting 37 February 3: Assessing Genomic Sequencing Workshop Information for Health Care Decision Making October 29-30: Meeting 38 July 23: Meeting 11 Workshop 2020 November 17: Generating Evidence for Genomic February 4: Meeting 22 Diagnostic Test Development Workshop August 18: Improving Genetics Education in March 24: The Role of Digital Health Technologies in Graduate and Continuing Health Professional Drug Development Workshop November 18: Meeting 12 Education Workshop March 25: Meeting 39 2011 August 19: Meeting 23 June 22-23: Meeting 40: Strategic Planning February 22−23: Meeting 13 December 8: Genomics-Enabled Learning Health Care Systems: Gathering and Using Genomic July 1: Meeting 41: Host Genomics Research and Data July 19: Integrating Large-Scale Genomic Information to Improve Patient Care and Research Collection Efforts Related to COVID-19 Information into Clinical Practice Workshop Workshop July 20: Meeting 14 November 10 & 12: Meeting 42: Implementation of December 9: Meeting 24 Strategic Plan November 15: Facilitating Development and Utilization of Genome-Based Diagnostic 2015 2021 Technologies Workshop March 10−11: Meeting 25 January 28: Meeting 43 November 16: Meeting 15 July 14−15: Meeting 26 March 15-16: Meeting 44 November 19: Applying an Implementation July 14-15: Meeting 45 Science Approach to Genomic Medicine Workshop October 5-6: Meeting 46 2020 Annual Report | 6

Read the entire page →

From page 7...

... Board on Health Sciences Policy Staff NAM Greenwall Fellow in Bioethics Andrew Pope, Ph.D., Senior Board Director Rachel Fabi, Ph.D., Upstate Medical University Bridget Borel, Program Coordinator ABOUT THE NATIONAL ACADEMIES The National Academy of Sciences, National Academy of Engineering, and National Academy of Medicine work together as the National Academies of Sciences, Engineering, and Medicine ("the Academies") to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions.

Read the entire page →

From page 8...

... The nation turns to the National Academies of Sciences, Engineering, and Medicine for independent, objective advice on issues that affect people's lives worldwide. www.nationalacademies.org To learn more about the Roundtable, visit nationalacademies.org/our-work/Roundtable-on genomics-and-precision-health

Read the entire page →

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.

Roundtable on Genomics and Precision Health: 2020 Annual Report Pages 1-8

Roundtable on Genomics and Precision Health: 2020 Annual Report
Pages 1-8